Dynamic control of terahertz (THz) waves at-will with an ultracompact device is important for THz technologies in biomedical imaging, telecommunications, detection, and beyond. However, tunable THz ...
BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback